XIAP and chronic myelogenous leukemia, BCR-ABL1 positive: Although it has been demonstrated that the nuclear localization of XIAP is an independent prognostic marker in breast cancer [120], little is known about the expression and subcellular localization relevance of XIAP in CML patient samples.